Overview

The Preemptive Analgesic Efficacy of Nefopam

Status:
Completed

Trial end date:
2016-01-01

Target enrollment:

Participant gender:

Summary

Nefopam is administered as a preemptive analgesic drug to the patient undergoing breast cancer surgery. It will be evaluated whether postoperative acute and chronic pain can be reduced.

Phase:

N/A

Details

Lead Sponsor:

Seoul National University Bundang Hospital

Treatments:

Nefopam